Back to Results
First PageMeta Content
Pharmacology / Attention-deficit hyperactivity disorder / Piperidines / Psychoactive drugs / Organofluorides / Antidepressant / Methylphenidate / Psychiatric medication / Attention deficit hyperactivity disorder / Medicine / Psychiatry / Health


Document Date: 2010-08-27 16:46:39

Open Document

File Size: 1,17 MB

Share Result on Facebook

City

Cambridge / /

Company

Newsweek / Springer Publishing Company / African Americans / Hispanics / New York Times / The Zito and associates / /

Continent

America / /

Country

United States / /

Currency

USD / /

Facility

National Institute of Mental Health / /

IndustryTerm

pharmaceutical / mental health services / efficacy oftheir products / /

MedicalCondition

mood disorders / ADHD / attention-deficitJhyperactivity disorder / attention deficit hyperactivity disorder / /

MedicalTreatment

multimodal treatment / /

Organization

Harvard Medical School / Food and Drug Administration / American Psychiatric Association / WHITE HOUSE / American Medical Association / FDA / American Academy of Child and Adolescent Psychiatry / National Institute of Mental Health / /

Person

Jane Henney / PETER BREGGIN / Steven Hyman / Jay Giedd / Riddle / Hillary Clinton / Al-Shabbout / Birmaher / Garcia / Hardin / Julie Zito / Ryan / Allan Tasman / Editorial / Safer / Jain / Joseph T. Coyle / David Satcher / Laurence Greenhill / /

Position

psychiatrist / President / Senator / King / director / Commissioner / First Lady / D. J . / Surgeon General / child psychiatrist / Co-Editor / /

Product

Prozac / Fluoxetine / Ritalin / /

ProvinceOrState

Maryland / Massachusetts / /

PublishedMedium

Newsweek / the Journal of the American Medical Association / New York Times / Journal of the American Medical Association / /

Technology

artificial intelligence / /

SocialTag